Timing of mTOR activation affects tuberous sclerosis complex neuropathology in mouse models

DMM Disease Models and Mechanisms

Volumn 6, Issue 5, 2013, Pages 1185-1197

  Magri, Laura ^a   Cominelli, Manuela ^b   Cambiaghi, Marco ^a   Cursi, Marco ^a   Leocani, Letizia ^a   Minicucci, Fabio ^a   Poliani, Pietro Luigi ^b   Galli, Rossella ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN;

ALEXANDER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DISEASE MODEL; EPILEPSY; GENE; GENE MUTATION; GLIA CELL; HIPPOCAMPUS; LIFESPAN; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RADIAL GLIA CELL; SPONTANEOUS EPILEPSY; SUBVENTRICULAR ZONE; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX; TUBEROUS SCLEROSIS COMPLEX 1 GENE; TUBEROUS SCLEROSIS COMPLEX 2 GENE;

ANIMALS; ANIMALS, NEWBORN; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SIZE; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; EMBRYO, MAMMALIAN; EMBRYONIC DEVELOPMENT; ENZYME ACTIVATION; EPILEPSY; GENE SILENCING; LONGEVITY; MACROCEPHALY; MICE; MUTAGENESIS; MYELIN SHEATH; NEUROGLIA; NEURONS; SIROLIMUS; STAT3 TRANSCRIPTION FACTOR; TIME FACTORS; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84883885410     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.012096     Document Type: Article

References (23)

1. Benvenuto, G., Li, S., Brown, S. J., Braverman, R., Vass, W. C., Cheadle, J. P., Halley, D. J., Sampson, J. R., Wienecke, R. and DeClue, J. E. (2000). The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19, 6306-6316.
2. Carson, R. P., Van Nielen, D. L., Winzenburger, P. A. and Ess, K. C. (2012). Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin. Neurobiol. Dis. 45, 369-380.
3. Crino, P. B., Nathanson, K. L. and Henske, E. P. (2006). The tuberous sclerosis complex. N. Engl. J. Med. 355, 1345-1356.
4. Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y. S., Reeve, M. P., Thiele, E., Egelhoff, J. C. et al. (2001). Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am. J. Hum. Genet. 68, 64-80.
5. Devlin, L. A., Shepherd, C. H., Crawford, H. and Morrison, P. J. (2006). Tuberous sclerosis complex: clinical features, diagnosis, and prevalence within Northern Ireland. Dev. Med. Child Neurol. 48, 495-499.
6. Ehninger, D., Han, S., Shilyansky, C., Zhou, Y., Li, W., Kwiatkowski, D. J., Ramesh, V. and Silva, A. J. (2008). Reversal of learning deficits in a Tsc2+/-mouse model of tuberous sclerosis. Nat. Med. 14, 843-848.
7. Feliciano, D. M., Su, T., Lopez, J., Platel, J. C. and Bordey, A. (2011). Single-cell Tsc1 knockout during corticogenesis generates tuber-like lesions and reduces seizure threshold in mice. J. Clin. Invest. 121, 1596-1607.
8. Feliciano, D. M., Quon, J. L., Su, T., Taylor, M. M. and Bordey, A. (2012). Postnatal neurogenesis generates heterotopias, olfactory micronodules and cortical infiltration following single-cell Tsc1 deletion. Hum. Mol. Genet. 21, 799-810.
9. Jansen, F. E., Braams, O., Vincken, K. L., Algra, A., Anbeek, P., Jennekens-Schinkel, A., Halley, D., Zonnenberg, B. A., van den Ouweland, A., van Huffelen, A. C. et al. (2008). Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations. Neurology 70, 908-915.
10. Magri, L., Cambiaghi, M., Cominelli, M., Alfaro-Cervello, C., Cursi, M., Pala, M., Bulfone, A., Garcìa-Verdugo, J. M., Leocani, L., Minicucci, F. et al. (2011). Sustained activation of mTOR pathway in embryonic neural stem cells leads to development of tuberous sclerosis complex-associated lesions. Cell Stem Cell 9, 447-462.
11. Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E. and Kwiatkowski, D. J. (2007). A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J. Neurosci. 27, 5546-5558.
12. Michelozzi, C., Di Leo, G., Galli, F., Silva Barbosa, F., Labriola, F., Sardanelli, F. and Cornalba, G. (2013). Subependymal nodules and giant cell tumours in tuberous sclerosis complex patients: prevalence on MRI in relation to gene mutation. Childs Nerv. Syst. 29, 249-254.
13. Paliouras, G. N., Hamilton, L. K., Aumont, A., Joppé, S. E., Barnabé-Heider, F. and Fernandes, K. J. (2012). Mammalian target of rapamycin signaling is a key regulator of the transit-amplifying progenitor pool in the adult and aging forebrain. J. Neurosci. 32, 15012-15026.
14. Petreanu, L. and Alvarez-Buylla, A. (2002). Maturation and death of adult-born olfactory bulb granule neurons: role of olfaction. J. Neurosci. 22, 6106-6113.
15. Rok, P., Kasprzyk-Obara, J., Domańska-Pakieła, D. and Jóźwiak, S. (2005). Clinical symptoms of tuberous sclerosis complex in patients with an identical TSC2 mutation. Med. Sci. Monit. 11, CR230-CR234.
16. Uhlmann, E. J., Apicelli, A. J., Baldwin, R. L., Burke, S. P., Bajenaru, M. L., Onda, H., Kwiatkowski, D. and Gutmann, D. H. (2002a). Heterozygosity for the tuberous sclerosis complex (TSC) gene products results in increased astrocyte numbers and decreased p27-Kip1 expression in TSC2+/-cells. Oncogene 21, 4050-4059.
17. Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K. and Gutmann, D. H. (2002b). Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann. Neurol. 52, 285-296.
18. van Eeghen, A. M., Black, M. E., Pulsifer, M. B., Kwiatkowski, D. J. and Thiele, E. A. (2012). Genotype and cognitive phenotype of patients with tuberous sclerosis complex. Eur. J. Hum. Genet. 20, 510-515.
19. van Eeghen, A. M., Nellist, M., van Eeghen, E. E. and Thiele, E. A. (2013). Central TSC2 missense mutations are associated with a reduced risk of infantile spasms. Epilepsy Res. 103, 83-87.
20. Way, S. W., McKenna, J., 3rd, Mietzsch, U., Reith, R. M., Wu, H. C. and Gambello, M. J. (2009). Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum. Mol. Genet. 18, 1252-1265.
21. Zeng, L. H., Rensing, N. R., Zhang, B., Gutmann, D. H., Gambello, M. J. and Wong, M. (2011). Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex. Hum. Mol. Genet. 20, 445-454.
22. Zhou, J., Shrikhande, G., Xu, J., McKay, R. M., Burns, D. K., Johnson, J. E. and Parada, L. F. (2011). Tsc1 mutant neural stem/progenitor cells exhibit migration deficits and give rise to subependymal lesions in the lateral ventricle. Genes Dev. 25, 1595-1600.
23. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K. and Messing, A. (2001). hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis 31, 85-94.